Alphafetoprotein in screening for congenital hypothyroidism
View/
Abstract
This study was conducted on 500 full-term neonates and 25 older patients with congenital hypothyroidism [CH], newly or previously diagnosed. Alphafetoprotein [AFP] was elevated in two neonates. In one, persistent elevation of AFP and thyroid stimulating hormone [TSH] with low thyroxine [T4] were found [congenital hypothyroidism]. In the other, AFP, TSH and T4 levels normalized [transient hypothyroidism]. The mean AFP level in new CH patients was significantly higher than in previously diagnosed patients, and was higher in CH patients than in controls. Significant relationships were found between AFP and T4, AFP and TSH, and AFP and age. AFP is a sensitive indicator of thyroid status and can be used as a screening test for hypothyroidism from the first day of life and in follow-up of CH patientsCitation
(2001). Alphafetoprotein in screening for congenital hypothyroidism. http://www.who.int/iris/handle/10665/119004
Relation
EMHJ - Eastern Mediterranean Health Journal, 7 (1-2), 171-180, 2001
Description
171-180ISSN
1020-3397Other Identifiers
http://applications.emro.who.int/emhj/0701_2/2001_7_1-2_171_180.pdfCollections
Language
EnglishMetadata
Show full item recordRelated items
Showing items related by title and MeSH subject.
-
Parental consanguinity among parents of neonates with congenital hypothyroidism in Isfahan
(2007)We determined the prevalence of congenital hypothyroidism and the rate of consanguinity among parents of hypothyroid neonates among 93 381 neonates born in 17 hospitals in Isfahan from May 2002 to April 2005. Serum thyroxine [T4] and thyroid stimulating hormone [TSH] levels were measured on the 3rd-7th day of birth and neonates with abnormal levels were recalled and the levels reassessed. Those with TSH </= 10 mIU/L and T4 < 6.5 micro g/dL on the second assay were considered hypothyroid. In all, 1038 neonates were recalled and 274 were diagnosed ... -
Screening for congenital hypothyroidism in the Islamic Republic of Iran: strategies, obstacles and future perspectives
(2002)The operational feasibility of a congenital hypothyroidism [CH] screening programme was assessed. Cord blood spot specimens were collected at seven Teheran hospitals and within the Damavand District health network. Cord thyroid-stimulating hormone [TSH] levels > or = 20 mU/L were recalled and levothyroxine [L-T4] therapy was started immediately after diagnosis of CH. Of 20,107 acceptable specimens, 22 neonates had CH [1:914 births]. The recall rate was 1.3%. Screening coverage was 90% of live births. Of all cord samples, only 0.2% were unacceptable ...
